B-Cell Targeted Therapies in Autoimmune Rheumatic Diseases...
Encyclopedia: Epratuzumab
Epratuzumab is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as lupus . , Biotechnology , Immunology , Oncology , Clinical Cancer Research Vol. 9, September 1, 2003 free full text , Clinical Cancer Research Vol. 11, July 15, 2005 free full text
Web Results
-
Epratuzumab - Wikipedia, the free encyclopedia
Epratuzumab is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as lupus ...
-
Definition of epratuzumab - National Cancer Institute Drug Dictionary
After binding to CD22, epratuzumab's predominant antitumor activity appears to be mediated through antibody-dependent cellular cytotoxicity (ADCC). ...
-
Combination Therapy of Rituxan and Epratuzumab Promising for ...
The combination of Rituxan (rituximab) and epratuzumab is reported to be well tolerated and effective in patients with relapsed or refractory B-cell ...
-
FDA Allows Resumption Of Lupus Trials With Epratuzumab
Nov 16, 2006 ... Immunomedics, Inc. (Nasdaq: IMMU), a biopharmaceutical company focused on developing therapeutic monoclonal antibodies, today announced that ...
-
Epratuzumab Reduced Disease Activity And Steroid Use In Patients ...
Jun 18, 2008 ... UCB has announced that data presented recently show that epratuzumab treatment demonstrated clinically meaningful improvements in moderate ...
Related in the Kosmos
Biology
Disease
Science
Medicine
Specialty (medicine)
Physiology
Health